Literature DB >> 28082455

Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.

Olga Nikolova1, Russell Moser2, Christopher Kemp2, Mehmet Gönen1,3, Adam A Margolin1.   

Abstract

Motivation: In recent years, vast advances in biomedical technologies and comprehensive sequencing have revealed the genomic landscape of common forms of human cancer in unprecedented detail. The broad heterogeneity of the disease calls for rapid development of personalized therapies. Translating the readily available genomic data into useful knowledge that can be applied in the clinic remains a challenge. Computational methods are needed to aid these efforts by robustly analyzing genome-scale data from distinct experimental platforms for prioritization of targets and treatments.
Results: We propose a novel, biologically motivated, Bayesian multitask approach, which explicitly models gene-centric dependencies across multiple and distinct genomic platforms. We introduce a gene-wise prior and present a fully Bayesian formulation of a group factor analysis model. In supervised prediction applications, our multitask approach leverages similarities in response profiles of groups of drugs that are more likely to be related to true biological signal, which leads to more robust performance and improved generalization ability. We evaluate the performance of our method on molecularly characterized collections of cell lines profiled against two compound panels, namely the Cancer Cell Line Encyclopedia and the Cancer Therapeutics Response Portal. We demonstrate that accounting for the gene-centric dependencies enables leveraging information from multi-omic input data and improves prediction and feature selection performance. We further demonstrate the applicability of our method in an unsupervised dimensionality reduction application by inferring genes essential to tumorigenesis in the pancreatic ductal adenocarcinoma and lung adenocarcinoma patient cohorts from The Cancer Genome Atlas. Availability and Implementation: : The code for this work is available at https://github.com/olganikolova/gbgfa. Contact: : nikolova@ohsu.edu or margolin@ohsu.edu. Supplementary information: Supplementary data are available at Bioinformatics online.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28082455      PMCID: PMC5860077          DOI: 10.1093/bioinformatics/btw836

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  40 in total

1.  Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data.

Authors:  In Sock Jang; Elias Chaibub Neto; Juistin Guinney; Stephen H Friend; Adam A Margolin
Journal:  Pac Symp Biocomput       Date:  2014

2.  BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

Authors:  Tess Orvis; Austin Hepperla; Vonn Walter; Ian J Davis; Bernard Weissman; Shujie Song; Jeremy Simon; Joel Parker; Matthew D Wilkerson; Nisarg Desai; Michael B Major; D Neil Hayes
Journal:  Cancer Res       Date:  2014-08-12       Impact factor: 12.701

Review 3.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

4.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

5.  Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.

Authors:  Pedro P Medina; Octavio A Romero; Takashi Kohno; Luis M Montuenga; Ruben Pio; Jun Yokota; Montse Sanchez-Cespedes
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

6.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

7.  Assessing the clinical utility of cancer genomic and proteomic data across tumor types.

Authors:  Yuan Yuan; Eliezer M Van Allen; Larsson Omberg; Nikhil Wagle; Ali Amin-Mansour; Artem Sokolov; Lauren A Byers; Yanxun Xu; Kenneth R Hess; Lixia Diao; Leng Han; Xuelin Huang; Michael S Lawrence; John N Weinstein; Josh M Stuart; Gordon B Mills; Levi A Garraway; Adam A Margolin; Gad Getz; Han Liang
Journal:  Nat Biotechnol       Date:  2014-06-22       Impact factor: 54.908

8.  Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors.

Authors:  Sarah M Haeger; Joshua J Thompson; Sean Kalra; Timothy G Cleaver; Daniel Merrick; Xiao-Jing Wang; Stephen P Malkoski
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

9.  Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer.

Authors:  S Mitsunaga; M Ikeda; S Shimizu; I Ohno; J Furuse; M Inagaki; S Higashi; H Kato; K Terao; A Ochiai
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

10.  The Reactome pathway knowledgebase.

Authors:  David Croft; Antonio Fabregat Mundo; Robin Haw; Marija Milacic; Joel Weiser; Guanming Wu; Michael Caudy; Phani Garapati; Marc Gillespie; Maulik R Kamdar; Bijay Jassal; Steven Jupe; Lisa Matthews; Bruce May; Stanislav Palatnik; Karen Rothfels; Veronica Shamovsky; Heeyeon Song; Mark Williams; Ewan Birney; Henning Hermjakob; Lincoln Stein; Peter D'Eustachio
Journal:  Nucleic Acids Res       Date:  2013-11-15       Impact factor: 16.971

View more
  7 in total

1.  Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines.

Authors:  Matthew G Rees; Brinton Seashore-Ludlow; Paul A Clemons
Journal:  Methods Mol Biol       Date:  2019

2.  Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.

Authors:  Chang Xu; Olga Nikolova; Ryan S Basom; Ryan M Mitchell; Reid Shaw; Russell D Moser; Heuijoon Park; Kay E Gurley; Michael C Kao; Carlos L Green; Franz X Schaub; Robert L Diaz; Hallie A Swan; In S Jang; Justin Guinney; Vijayakrishna K Gadi; Adam A Margolin; Carla Grandori; Christopher J Kemp; Eduardo Méndez
Journal:  Clin Cancer Res       Date:  2018-03-29       Impact factor: 12.531

3.  A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines.

Authors:  Mehmet Gönen; Barbara A Weir; Glenn S Cowley; Francisca Vazquez; Yuanfang Guan; Alok Jaiswal; Masayuki Karasuyama; Vladislav Uzunangelov; Tao Wang; Aviad Tsherniak; Sara Howell; Daniel Marbach; Bruce Hoff; Thea C Norman; Antti Airola; Adrian Bivol; Kerstin Bunte; Daniel Carlin; Sahil Chopra; Alden Deran; Kyle Ellrott; Peddinti Gopalacharyulu; Kiley Graim; Samuel Kaski; Suleiman A Khan; Yulia Newton; Sam Ng; Tapio Pahikkala; Evan Paull; Artem Sokolov; Hao Tang; Jing Tang; Krister Wennerberg; Yang Xie; Xiaowei Zhan; Fan Zhu; Tero Aittokallio; Hiroshi Mamitsuka; Joshua M Stuart; Jesse S Boehm; David E Root; Guanghua Xiao; Gustavo Stolovitzky; William C Hahn; Adam A Margolin
Journal:  Cell Syst       Date:  2017-10-04       Impact factor: 10.304

4.  Machine Learning and Systems Biology Approaches to Characterize Dosage-Based Gene Dependencies in Cancer Cells.

Authors:  Kevin Meng-Lin; Choong Yong Ung; Taylor M Weiskittel; Alex Chen; Cheng Zhang; Cristina Correia; Hu Li
Journal:  J Bioinform Syst Biol       Date:  2021-02-26

Review 5.  Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review.

Authors:  Sorayya Rezayi; Sharareh R Niakan Kalhori; Soheila Saeedi
Journal:  Biomed Res Int       Date:  2022-04-07       Impact factor: 3.246

6.  Identifying Tissue- and Cohort-Specific RNA Regulatory Modules in Cancer Cells Using Multitask Learning.

Authors:  Milad Mokhtaridoost; Philipp G Maass; Mehmet Gönen
Journal:  Cancers (Basel)       Date:  2022-10-09       Impact factor: 6.575

7.  A Wavelet-Based Learning Model Enhances Molecular Prognosis in Pancreatic Adenocarcinoma.

Authors:  Binhua Tang; Yu Chen; Yuqi Wang; Jiafei Nie
Journal:  Biomed Res Int       Date:  2021-10-16       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.